Marinova is a progressive Australian biotechnology company focused on the research, development and manufacture of high purity fucoidan compounds.

Founded in 2003 and now established as the leader in its field, Marinova is recognised globally for the quality and efficacy of its fucoidan products. We are also renowned for our commitment to innovation in all facets of our business, from sustainable harvesting practices and advanced manufacturing technologies through to the research, development and validation of unique fucoidan fractions. Our proprietary aqueous extraction process generates high purity fucoidan compounds without the use of harsh chemicals, solvents or high temperatures. The result: a portfolio of highly characterised fucoidan extracts with superior bioactivity.

Marinova’s capabilities extend from highly characterised fractions for medical device applications and pharmaceutical research, through to high purity, certified organic fucoidan extracts for nutritional and cosmetic formulations.

The standing of our products is testament to the quality of the science upon which they are based. Marinova maintains an extensive research program and actively collaborates with leading universities and contract research organisations. Our scientists are authorities on the structure and bioactivity of algal polysaccharides. They are widely published and possess an unrivalled understanding of the physical and chemical properties of fucoidan compounds and how these properties may be modified to enhance efficacy.

This combination of scientific acumen and unique manufacturing technologies has been instrumental to our success. Marinova stands alone as the world's only producer of high purity, certified organic fucoidan extracts with global regulatory acceptance. 

No one knows fucoidan like Marinova – the fucoidan experts.